Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 60 results.
User Information
Export Records
  1. 1.   Development of a proficiency testing program for HPV serology assays used to evaluate antibody responses in vaccine trials
  2. Miller, Cheryl; Kemp,Troy; Pinto,Ligia
  3. Journal of Immunological Methods. 2023, Nov 08; 113585.
  1. 2.   A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays
  2. Pinto,Ligia; Shawar, Ribhi M; O'Leary, Brendan; Kemp,Troy; Cherry, James; Thornburg, Natalie; Miller, Cheryl N; Gallagher, Pamela S; Stenzel, Timothy; Schuck, Brittany; Owen, S Michele; Kondratovich, Marina; Satheshkumar, Panayampalli S; Schuh, Amy; Lester, Sandra; Cassetti, M Cristina; Sharpless, Norman E; Gitterman, Steven; Lowy, Douglas R
  3. Microbiology Spectrum. 2022, Jan 12; e0156421.
  1. 3.   Sensitivity of Oncogenic KRAS-Expressing Cells to CDK9 Inhibition
  2. Lai, Lick Pui; Brel, Viviane; Sharma, Kanika; Frappier, Julia; Le-Henanf, Nadia; Vivet, Bertrand; Muzet, Nicolas; Schell, Emilie; Morales, Renaud; Rooney, Eamonn; Basse, Nicolas; Yi,Ming; Lacroix, Frederic; Holderfield, Matthew; Englaro, Walter; Marcireau, Christophe; Debussche, Laurent; Nissley,Dwight; McCormick, Frank
  3. SLAS DISCOVERY. 2021, Apr 24; 26(7, SI): 922-932.
  1. 4.   LC-MS-sMRM method development and validation of different classes of pain panel drugs and analysis of clinical urine samples
  2. Masood, M Athar; Veenstra, Timothy D
  3. Basic & clinical pharmacology & toxicology. 2020, Nov 01;
  1. 5.   Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor
  2. Helman, Elena; Nguyen, Minh; Karlovich, Chris; Despain, Darrin; Choquette, A Karin; Spira, Alexander I; Yu, Helena A; Camidge, D Ross; Harding, Thomas C; Lanman, Richard B; Simmons, Andrew D
  3. Clinical lung cancer. 2018, Nov; 19(6): 518-530.e7.
  1. 6.   Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model
  2. Jung, Jaeyun; Jang, Kiwon; Ju, Jung Min; Lee, Eunji; Lee, Jong Won; Kim, Hee Jung; Kim, Jisun; Lee, Sae Byul; Ko, Beom Seok; Son, Byung Ho; Lee, Hee Jin; Gong, Gyungyup; Ahn, Sei Yeon; Choi, Jung Kyoon; Singh, Shree Ram; Chang, Suhwan
  3. Cancer Letters. 2018, Aug 01; 428: 127-138.
  1. 7.   LC-MS-sMRM Method Development and Validation of Different Classes of Pain Panel Drugs and Analysis of Clinical Urine Samples
  2. Athar Masood, M; Veenstra, Timothy D
  3. Basic & Clinical Pharmacology & Toxicology. 2017, Aug 26;
  1. 8.   Similarity in Recombination Rate Estimates Highly Correlates with Genetic Differentiation in Humans
  2. Laayouni, H. L. H.; Montanucci, L.; Sikora, M.; Mele, M.; Dall'Olio, G. M.; Lorente-Galdos, B.; McGee, K. M.; Graffelman, J.; Awadalla, P.; Bosch, E.; Comas, D.; Navarro, A.; Calafell, F.; Casals, F.; Bertranpetit, J.
  3. Plos One. 2011, Mar; 6(3): 8.
  1. 9.   Admixture Mapping Comes of Age
  2. Winkler, C. A.; Nelson, G. W.; Smith, M. W.
  3. Annual review of genomics and human genetics. 2010, Sep 22; 11: 65-89.
  1. 10.   mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities
  2. Liu, H. F.; D'Andrade, P.; Fulmer-Smentek, S.; Lorenzi, P.; Kohn, K. W.; Weinstein, J. N.; Pommier, Y.; Reinhold, W. C.
  3. Molecular Cancer Therapeutics. 2010, May; 9(5): 1080-1091.
  1. 11.   Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
  2. Stuelten, C. H.; Mertins, S. D.; Busch, J. I.; Gowens, M.; Scudiero, D. A.; Burkett, M. W.; Hite, K. M.; Alley, M.; Hollingshead, M.; Shoemaker, R. H.; Niederhuber, J. E.
  3. Stem Cells. 2010, Apr; 28(4): 649-660.
  1. 12.   Exon Array Analyses across the NCI-60 Reveal Potential Regulation of TOP1 by Transcription Pausing at Guanosine Quartets in the First Intron
  2. Reinhold, W. C.; Mergny, J. L.; Liu, H. F.; Ryan, M.; Pfister, T. D.; Kinders, R.; Parchment, R.; Doroshow, J.; Weinstein, J. N.; Pommier, Y.
  3. Cancer Research. 2010, Mar; 70(6): 2191-2203.
  1. 13.   Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
  2. Chen, L.; Kwon, Y. D.; Zhou, T. Q.; Wu, X. L.; O'Dell, S.; Cavacini, L.; Hessell, A. J.; Pancera, M.; Tang, M.; Xu, L.; Yang, Z. Y.; Zhang, M. Y.; Arthos, J.; Burton, D. R.; Dimitrov, D. S.; Nabel, G. J.; Posner, M. R.; Sodroski, J.; Wyatt, R.
  3. Science. 2009 326(5956): 1123-1127.
  1. 14.   A mutation in KIR3DS1 that results in truncation and lack of cell surface expression
  2. Martin, M. P.; Pascal, V.; Yeager, M.; Phair, J.; Kirk, G. D.; Hoots, K.; O'Brien, S. J.; Anderson, S. K.; Carrington, M.
  3. Immunogenetics. 2007, Oct; 59(10): 823-829.
  1. 15.   Enhanced soluble protein expression using two new fusion tags
  2. Chatterjee, D. K.; Esposito, D.
  3. Protein Expression and Purification. 2006, MAR; 46(1): 122-129.
  1. 16.   Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen
  2. Huang, R.; Wallqvist, A.; Covell, D. G.
  3. Genomics. 2006, MAR; 87(3): 315-328.
  1. 17.   Inhibition of transcription factor NF-kappa B signaling proteins IKK beta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
  2. Liang, M. C.; Bardhan, S.; Pace, E. A.; Rosman, D.; Beutler, J. A.; Porco, J. A.; Gilmore, T. D.
  3. Biochemical Pharmacology. 2006, FEB 28; 71(5): 634-645.
  1. 18.   Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies
  2. Zhu, Z. Y.; Dimitrov, A. S.; Bossart, K. N.; Crameri, G.; Bishop, K. A.; Choudhry, V.; Mungall, B. A.; Feng, Y. R.; Choudhary, A.; Zhang, M. Y.; Feng, Y.; Wang, L. F.; Xiao, X. D.; Eaton, B. T.; Broder, C. C.; Dimitrov, D. S.
  3. Journal of Virology. 2006, JAN; 80(2): 891-899.
  1. 19.   Evaluating chemical structure similarity as an indicator of cellular growth inhibition
  2. Wallqvist, A.; Huang, R. L.; Thanki, N.; Covell, D. G.
  3. Journal of Chemical Information and Modeling. 2006, JAN-FEB; 46(1): 430-437.
  1. 20.   Multicolor fluorescence-based approaches for imaging cytokine-induced alterations in the neovascularization, growth, metastasis, and apoptosis of murine neuroblastoma tumors
  2. Stauffer, J. K.; Khan, T.; Salcedo, R.; Hixon, J. A.; Lincoln, E.; Back, T. C.; Wigginton, J. M.
  3. Journal of Immunotherapy. 2006, MAR-APR; 29(2): 151-164.
  1. 21.   Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail
  2. Wyss, S.; Dimitrov, A. S.; Baribaud, F.; Edwards, T. G.; Blumenthal, R.; Hoxie, J. A.
  3. Journal of Virology. 2005, OCT; 79(19): 12231-12241.
  1. 22.   Drugs aimed at targeting characteristic karyotypic phenotypes of cancer cells
  2. Wallqvist, A.; Huang, R.; Covell, D. G.; Roschke, A. V.; Gelhaus, K. S.; Kirsch, I. R.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1559-1568.
  1. 23.   A rhesus macaque radiation hybrid map and comparative analysis with the human genome
  2. Murphy, W. J.; Agarwala, R.; Schaffer, A. A.; Stephens, R.; Smith, C.; Crumpler, N. J.; David, V. A.; O'Brien, S. J.
  3. Genomics. 2005, OCT; 86(4): 383-395.
  1. 24.   Effects of DNA mass on multiple displacement whole genome amplification and genotyping performance
  2. Bergen, A. W.; Qi, Y.; Haque, K. A.; Welch, R. A.; Chanock, S. J.
  3. BMC Biotechnology. 2005, SEP 16; 5
  1. 25.   Transmembrane inhibitors of P-glycoprotein, an ABC transporter
  2. Tarasova, N. I.; Seth, R.; Tarasov, S. G.; Kosakowska-Cholody, T.; Hrycyna, C. A.; Gottesman, M. M.; Michejda, C. J.
  3. Journal of Medicinal Chemistry. 2005, JUN 2; 48(11): 3768-3775.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel